Literature DB >> 30723523

Cancer-associated Retinopathy Developing After 10 Years of Complete Breast Cancer Remission.

Nozomi Igarashi1, Hiromasa Sawamura1, Toshikatsu Kaburaki1, Makoto Aihara1.   

Abstract

A 73-year-old female with a past medical history of breast cancer, who 10 years earlier experienced complete remission, complained of bilateral visual field disturbances and photopsia, 2 months prior. Tumour recurrence and metastatic lesions were not found during the medical examination, but antibodies against recoverin were detected in her serum. Despite immunosuppressive treatment with prednisolone and plasmapheresis, rapid and diffuse degeneration of the patient's photoreceptors and deterioration of her visual field were observed. This is a rare case of cancer-associated retinopathy with a long interval (10 years) between the diagnosis of the malignancy and visual loss.

Entities:  

Keywords:  Cancer-associated retinopathy; breast cancer; recoverin

Year:  2018        PMID: 30723523      PMCID: PMC6351012          DOI: 10.1080/01658107.2018.1460761

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  24 in total

Review 1.  Cancer-induced, immune-mediated ocular degenerations.

Authors:  Charles E Thirkill
Journal:  Ocul Immunol Inflamm       Date:  2005 Apr-Jun       Impact factor: 3.070

Review 2.  Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.

Authors:  J Guy; N Aptsiauri
Journal:  Arch Ophthalmol       Date:  1999-04

3.  Mechanisms of photoreceptor cell death in cancer-associated retinopathy.

Authors:  T Maeda; A Maeda; I Maruyama; K I Ogawa ; Y Kuroki; H Sahara; N Sato; H Ohguro
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-03       Impact factor: 4.799

4.  Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines.

Authors:  A Maeda; H Ohguro; T Maeda; I Wada; N Sato; Y Kuroki; T Nakagawa
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

5.  Acute zonal occult outer retinopathy: a long-term follow-up study.

Authors:  J Donald Gass; Anita Agarwal; Ingrid U Scott
Journal:  Am J Ophthalmol       Date:  2002-09       Impact factor: 5.258

Review 6.  Paraneoplastic retinopathies and optic neuropathies.

Authors:  Jane W Chan
Journal:  Surv Ophthalmol       Date:  2003 Jan-Feb       Impact factor: 6.048

Review 7.  Autoimmune retinopathy: a review and summary.

Authors:  John R Heckenlively; Henry A Ferreyra
Journal:  Semin Immunopathol       Date:  2008-04-12       Impact factor: 9.623

8.  Clinical and immunologic aspects of cancer-associated retinopathy.

Authors:  Hiroshi Ohguro; Yumiko Yokoi; Ikuyo Ohguro; Kazuhisa Mamiya; Futoshi Ishikawa; Hitoshi Yamazaki; Tomomi Metoki; Yoshiko Takano; Tadashi Ito; Mitsuru Nakazawa
Journal:  Am J Ophthalmol       Date:  2004-06       Impact factor: 5.258

9.  Management and monitoring of cancer-associated retinopathy.

Authors:  J L Keltner; C E Thirkill; N K Tyler; A M Roth
Journal:  Arch Ophthalmol       Date:  1992-01

Review 10.  Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy.

Authors:  Grazyna Adamus
Journal:  Autoimmun Rev       Date:  2009-01-23       Impact factor: 9.754

View more
  2 in total

1.  Autoimmune retinopathy: clinical, electrophysiological, and immunological features in nine patients with long-term follow-up.

Authors:  Khaled Safadi; Itay Chowers; Eyal Banin; Boris Rosin; Liran Tiosano; Radgonde Amer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-09-30       Impact factor: 3.117

Review 2.  Ocular Paraneoplastic Syndromes.

Authors:  Joanna Przeździecka-Dołyk; Anna Brzecka; Maria Ejma; Marta Misiuk-Hojło; Luis Fernando Torres Solis; Arturo Solís Herrera; Siva G Somasundaram; Cecil E Kirkland; Gjumrakch Aliev
Journal:  Biomedicines       Date:  2020-11-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.